<DOC>
	<DOCNO>NCT02201238</DOCNO>
	<brief_summary>This research study conduct characterize pharmacokinetic property new topical medication ( MFC51123 ) contain two active ingredient ( diclofenac menthol ) two formulation package . One formulation package form gel aluminum tube one form gel roll-on applicator bottle . Additionally , comparison , pharmacokinetic property market diclofenac gel oral diclofenac treatment also characterize . This topical diclofenac/menthol gel develop treat mild moderate pain inflammation , acute sport injury , sprain strain . The rationale conduct study prove repeat topical treatment new diclofenac + menthol formulation either two package result unsafe systemic exposure .</brief_summary>
	<brief_title>Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel Oral Diclofenac Sodium</brief_title>
	<detailed_description />
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Participants age 18 50 year Body mass index 1928 ( kg/m2 ) Pregnant lactate female Participants intolerance hypersensitivity study material Participants positive result HIV , Hepatitis B Hepatitis C Participants skin lesion site application Participants history alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>